Cargando…

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis in cancer cells without causing damage to normal cells. However, some tumors are resistant to TRAIL monotherapy and clinical studies assessing targeted agents towards the TRAIL receptor have failed to sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noor, Alfiah, Umelo, Ijeoma Adaku, Kronenberger, Peter, Giron, Philippe, De Vlieghere, Elly, De Wever, Olivier, Teugels, Erik, De Grève, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033352/ https://www.ncbi.nlm.nih.gov/pubmed/29983892 http://dx.doi.org/10.18632/oncotarget.25618

Ejemplares similares

Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
por: Chen, Gang, et al.
Publicado: (2013)

Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
por: Umelo, Ijeoma Adaku, et al.
Publicado: (2015)

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
por: Chen, Gang, et al.
Publicado: (2012)

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
por: Chen, Gang, et al.
Publicado: (2020)

miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
por: Chen, Gang, et al.
Publicado: (2013)

Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer
por: Umelo, Ijeoma, et al.
Publicado: (2015)

Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector
por: Noor, Alfiah, et al.
Publicado: (2018)

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
por: Noeparast, Amir, et al.
Publicado: (2019)

Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
por: Chen, Gang, et al.
Publicado: (2010)

Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer
por: Giron, Philippe, et al.
Publicado: (2021)

Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers
por: De Vlieghere, Elly, et al.
Publicado: (2016)

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
por: Noeparast, Amir, et al.
Publicado: (2016)

Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer
por: Noeparast, Amir, et al.
Publicado: (2018)

Stromal Modulators of TGF-β in Cancer
por: Costanza, Brunella, et al.
Publicado: (2017)

Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
por: De Greve, Jacques, et al.
Publicado: (2020)

Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection
por: Melsens, Elodie, et al.
Publicado: (2017)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

Marco Polo
por: Heers, Jacques
Publicado: (1985)

Hypoxia imaging with (18)F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
por: Melsens, Elodie, et al.
Publicado: (2018)

Age and cellular context influence rectal prolapse formation in mice with caecal wall colorectal cancer xenografts
por: Tommelein, Joke, et al.
Publicado: (2016)

Drosophila Polo Kinase Is Required for Cytokinesis
por: Carmena, Mar, et al.
Publicado: (1998)

Polo kinase: the choreographer of the mitotic stage?
Publicado: (1996)

Regulation of the polo kinase during cytokinesis
por: Kachaner, David
Publicado: (2015)

Polo-like kinase 1 is involved in apoptosis, invasion, and metastasis of pancreatic ductal adenocarcinoma
por: Mao, Yonghuan, et al.
Publicado: (2020)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety
por: Sermijn, Erica, et al.
Publicado: (2016)

Polo-like kinase is required for Golgi and bilobe biogenesis in Trypanosoma brucei
por: de Graffenried, Christopher L., et al.
Publicado: (2008)

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
por: Fischer, Suzanne, et al.
Publicado: (2023)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Mitotic spindle formation in the absence of Polo kinase
por: Kim, Juyoung, et al.
Publicado: (2022)

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
por: de Cárcer, Guillermo
Publicado: (2019)

Polo-like kinase 1 (PLK1) and protein phosphatase 6 (PP6) regulate DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylation in mitosis
por: Douglas, Pauline, et al.
Publicado: (2014)

Polo-like kinase 1 inhibition sensitizes neuroblastoma cells for vinca alkaloid-induced apoptosis
por: Czaplinski, Sebastian, et al.
Publicado: (2015)

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009)

A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers
por: Vermeij, Joanna, et al.
Publicado: (2008)

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families
por: Krajc, Mateja, et al.
Publicado: (2008)

Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1
por: Murugan, Ravichandran N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_afn7tl965vm6mnds2k4ebc6v4g